Summary of National Advisory Committee on Immunization (NACI) statement: Recommendation on the use of mRNA COVID-19 vaccines in adolescents 12 to 17 years of age

On this page

Overview

NACI continues to recommend:

To see the full update, please visit NACI Recommendation on the use of mRNA vaccines in adolescents 12 to 17 years of age.

What you need to know

To see the full update, please visit NACI Recommendation on the use of mRNA vaccines in adolescents 12 to 17 years of age.

Quotes

"Following Health Canada's recent authorization for the use of Moderna in adolescents 12 to 17 years of age, NACI is recommending that a complete series with an mRNA COVID-19 vaccine should be offered to adolescents 12 to 17 years of age without contraindications. Both mRNA vaccines are very effective at preventing COVID-19 illness and have so far continued to show good effectiveness against variants, including Delta.

It is important to be aware that rare cases of myocarditis/pericarditis following receipt of an mRNA vaccine have been reported, and NACI continues to follow the evidence related to this safety issue closely. We have seen that myocarditis/pericarditis appears to be reported more often in young males and after the second dose. More recently, we have seen that there may also be a difference in risk between different vaccine products, and this continues to be investigated. Considering the rare risks and known benefits of COVID-19 vaccines, vaccination is strongly recommended for adolescents to prevent severe illness and to allow teenagers to safely resume activities central to their health and well-being, such as in-person schooling and events with family and friends."

Dr. Shelley Deeks, NACI Chair

"I would like to thank the experts on NACI for their continued guidance on the use of mRNA vaccines in adolescents. Since May, provinces and territories have done a great job rolling out the Pfizer-BioNTech vaccine to adolescents and have made significant progress in increasing vaccine coverage in this age group across Canada. As of August 21st, more than 76% of adolescents aged 12 to 17 years have received one dose and more than 63% are fully vaccinated. NACI's updated recommendations will help provinces and territories continue to rollout their adolescent COVID-19 vaccination programs to better protect the health and wellbeing of our adolescents, their families and communities."

Dr. Theresa Tam, Chief Public Health Officer

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: